With the global epidemic of obesity showing no signs of waning, physicians should be aware of the cardiac side effects of weight-loss drugs.
May 2017
Advertisement
Advertisement
Trending on HCPLive
1
Tirzepatide Demonstrates Cardioprotective Effects in T2D With ASCVD
2
Phase 3 Dermatomyositis Trial Sees Brepocitinib Meet Primary Endpoint
3
Socrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Study
4
Omalizumab-Facilitated OIT Enables Maintenance Dosing in Food Allergy
5